Skip to the reading

A little clarity,
from Summer.

Explore +

The compound guides

Epitalon.
Stay curious.

Epitalon is often wrapped in talk about aging and sleep. This guide untangles the similar names and explains why the unanswered human questions matter.

Start a Promise Peptides consultation

Summer may earn money when readers become Promise patients.

Promise Peptides prescribes now through licensed U.S. providers. A provider reviews each request and decides; not everyone qualifies. U.S. patients only. Availability varies by state and treatment. Compounded medicines are not FDA-approved.

The long view, from a small courtyard.

Epitalon and epithalamin are different substances. Their evidence cannot be merged.

Similar names need a second look.

Epitalon is a lab-made peptide with four amino acids, the building blocks of proteins. It was modeled on an extract from the pineal gland of cattle. The pineal gland is a small gland in the brain involved in making melatonin, a sleep hormone.

The extract is called epithalamin. It is a different substance. Older human research on that extract cannot be treated as research on epitalon. Epithalon is another spelling of epitalon.

A laboratory finding is a beginning.

Researchers have studied epitalon in cells and animals, including work on telomeres. Telomeres are protective ends on chromosomes, the structures that hold genetic information. A change in a cell experiment does not show that a person will live longer or age differently.

Most epitalon research comes from one research group in Russia. The FDA found three human studies of epitalon itself, but no adequate evidence for insomnia, or ongoing trouble sleeping.

Epitalon has no FDA-approved use. The FDA’s review found no adequate human safety studies. A lack of reported side effects cannot fill that gap. It leaves the question open rather than supplying reassurance.

Read the status with the concerns.

The FDA’s page current as of April 22, 2026, places epitalon under “nominated but withdrawn.” That is a withdrawn request to consider the ingredient for compounding, not FDA clearance or approval. FDA continues to publish safety concerns.

Those concerns include the possibility of immune reactions and poorly described ingredient quality. Its review also raises a theoretical cancer concern related to telomeres. That is a concern about a possible mechanism, not evidence that epitalon has caused cancer in people.

Questions that leave room for an answer.

Promise Peptides offers prescription peptide care. That service listing does not change FDA status. Compounded medicine is not FDA-approved. Provider review and the pharmacy’s separate assessment of what it can lawfully prepare both matter.

  • Does the cited research concern epitalon or the older extract?
  • Were the findings in people, animals or cells?
  • What human safety information is missing?

If sleep is what brought you here, sleep, calm and peptides starts with that question without treating a laboratory finding as an answer.

Read a little further.

When a question needs a provider.

A consultation is a place for a licensed review of your health. It can end without a prescription. There is room for that answer too.

Bring a care question to Promise Peptides

Summer may earn money when readers become Promise patients.

Promise Peptides prescribes now through licensed U.S. providers. A provider reviews each request and decides; not everyone qualifies. U.S. patients only. Availability varies by state and treatment. Compounded medicines are not FDA-approved.